| Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. F Cosentino, S Patton, LV d'Uscio, ER Werner, G Werner-Felmayer, ... The Journal of clinical investigation 101 (7), 1530-1537, 1998 | 465 | 1998 |
| Angiotensin II Increases Tissue Endothelin and Induces Vascular Hypertrophy: Reversal by ETA-Receptor Antagonist P Moreau, LV d’Uscio, S Shaw, H Takase, M Barton, TF Lüscher Circulation 96 (5), 1593-1597, 1997 | 449 | 1997 |
| Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. MR Tschudi, M Barton, NA Bersinger, P Moreau, F Cosentino, G Noll, ... The Journal of clinical investigation 98 (4), 899-905, 1996 | 356 | 1996 |
| Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension HH Dao, R Essalihi, C Bouvet, P Moreau Cardiovascular research 66 (2), 307-317, 2005 | 353 | 2005 |
| Anatomic heterogeneity of vascular aging: role of nitric oxide and endothelin M Barton, F Cosentino, RP Brandes, P Moreau, S Shaw, TF Lüscher Hypertension 30 (4), 817-824, 1997 | 308 | 1997 |
| Angiotensin II Increases Vascular and Renal Endothelin-1 and Functional Endothelin Converting Enzyme Activityin Vivo: Role of ETAReceptors for Endothelin Regulation M Barton, S Shaw, P Moreau, TF Lüscher Biochemical and biophysical research communications 238 (3), 861-865, 1997 | 269 | 1997 |
| ETA Receptor Blockade Prevents Increased Tissue Endothelin-1, Vascular Hypertrophy, and Endothelial Dysfunction in Salt-Sensitive Hypertension M Barton, LV d’Uscio, S Shaw, P Meyer, P Moreau, TF Luscher Hypertension 31 (1), 499-504, 1998 | 214 | 1998 |
| Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention FZ Kettani, A Dragomir, R Côté, L Roy, A Bérard, L Blais, L Lalonde, ... Stroke 40 (1), 213-220, 2009 | 211 | 2009 |
| Effects of Chronic ETA-Receptor Blockade in Angiotensin II-Induced Hypertension LV d’Uscio, P Moreau, S Shaw, H Takase, M Barton, TF Luscher Hypertension 29 (1), 435-441, 1997 | 185 | 1997 |
| Structure and function of small arteries in salt-induced hypertension: effects of chronic endothelin-subtype-A–receptor blockade LV d’Uscio, M Barton, S Shaw, P Moreau, TF Lüscher Hypertension 30 (4), 905-911, 1997 | 148 | 1997 |
| Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency: effect of verapamil and trandolapril H Takase, P Moreau, CF Küng, E Nava, TF Lüscher Hypertension 27 (1), 25-31, 1996 | 145 | 1996 |
| L-NAME hypertension alters endothelial and smooth muscle function in rat aorta: prevention by trandolapril and verapamil CF Küng, P Moreau, H Takase, TF Lüscher Hypertension 26 (5), 744-751, 1995 | 139 | 1995 |
| Dysfunctional renal nitric oxide synthase as a determinant of salt-sensitive hypertension: mechanisms of renal artery endothelial dysfunction and role of endothelin for … M Barton, I Vos, S Shaw, P Boer, LV D'USCIO, HJ GRO, TJ Rabelink, ... Journal of the American Society of Nephrology 11 (5), 835-845, 2000 | 134 | 2000 |
| A new model of isolated systolic hypertension induced by chronic warfarin and vitamin K1 treatment R Essalihi, HH Dao, N Yamaguchi, P Moreau American journal of hypertension 16 (2), 103-110, 2003 | 130 | 2003 |
| Sequential activation of matrix metalloproteinase 9 and transforming growth factor β in arterial elastocalcinosis C Bouvet, S Moreau, J Blanchette, D de Blois, P Moreau Arteriosclerosis, thrombosis, and vascular biology 28 (5), 856-862, 2008 | 124 | 2008 |
| Extracellular signal-regulated kinase mediates phosphorylation of tropomyosin-1 to promote cytoskeleton remodeling in response to oxidative stress: impact on membrane blebbing F Houle, S Rousseau, N Morrice, M Luc, S Mongrain, CE Turner, ... Molecular biology of the cell 14 (4), 1418-1432, 2003 | 122 | 2003 |
| Alterations to the nitric oxide pathway in the spontaneously hypertensive rat E Nava, AL Farré, C Moreno, S Casado, P Moreau, F Cosentino, ... Journal of hypertension 16 (5), 609-615, 1998 | 122 | 1998 |
| Blood pressure and vascular effects of endothelin blockade in chronic nitric oxide–deficient hypertension P Moreau, H Takase, CF Küng, S Shaw, TF Lüscher Hypertension 29 (3), 763-769, 1997 | 113 | 1997 |
| Structure and reactivity of small arteries in aging P Moreau, LV d'Uscio, TF Lüscher Cardiovascular research 37 (1), 247-253, 1998 | 112 | 1998 |
| The time window of apoptosis: a new component in the therapeutic strategy for cardiovascular remodeling. P Hamet, P Moreau, TV Dam, SN Orlov, BS Tea, D De Blois, J Tremblay Journal of hypertension. Supplement: Official Journal of the International …, 1996 | 110 | 1996 |
Matthias Barton, MDProfessor of Cardiology, University of Zurich在 access.uzh.ch 的电子邮件经过验证
